Corrigendum to "Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series".

IF 3.4 3区医学 Q2 PHARMACOLOGY & PHARMACY Therapeutic Advances in Psychopharmacology Pub Date : 2024-05-28 eCollection Date: 2024-01-01 DOI:10.1177/20451253241258536

引用次数: 0

Abstract

[This corrects the article DOI: 10.1177/20451253231165169.].

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

塞马鲁肽用于治疗对二甲双胍无应答的抗精神病药物相关体重增加患者--病例系列》的更正。

[This corrects the article DOI: 10.1177/20451253231165169.].

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Therapeutic Advances in Psychopharmacology Multiple-

CiteScore

7.90

自引率

2.40%

发文量

审稿时长

10 weeks

期刊介绍： Therapeutic Advances in Psychopharmacology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of psychopharmacology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in psychopharmacology, providing a forum in print and online for publishing the highest quality articles in this area.

期刊最新文献

Disrupted emotion regulation and spontaneous neural activity in panic disorder: a resting-state fMRI study. Prevalence and risk factors of PTSD symptoms: a 3-month follow-up study. Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia. Use of an injection of aripiprazole given once every 2 months (Abilify Asimtufii^®) in people with bipolar I disorder: a Plain Language Summary of Publication. Exploring the clinical factors affecting lithium dose and plasma level and the effect of brand.